JP2022511732A5 - - Google Patents

Info

Publication number
JP2022511732A5
JP2022511732A5 JP2021527977A JP2021527977A JP2022511732A5 JP 2022511732 A5 JP2022511732 A5 JP 2022511732A5 JP 2021527977 A JP2021527977 A JP 2021527977A JP 2021527977 A JP2021527977 A JP 2021527977A JP 2022511732 A5 JP2022511732 A5 JP 2022511732A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
coo
cooh
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021527977A
Other languages
English (en)
Japanese (ja)
Other versions
JP7558165B2 (ja
JP2022511732A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062798 external-priority patent/WO2020112542A1/en
Publication of JP2022511732A publication Critical patent/JP2022511732A/ja
Publication of JP2022511732A5 publication Critical patent/JP2022511732A5/ja
Application granted granted Critical
Publication of JP7558165B2 publication Critical patent/JP7558165B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021527977A 2018-11-29 2019-11-22 β-ラクタマーゼ阻害剤を含む組み合わせ組成物およびその使用 Active JP7558165B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862773063P 2018-11-29 2018-11-29
US62/773,063 2018-11-29
US201862777643P 2018-12-10 2018-12-10
US62/777,643 2018-12-10
US201962796524P 2019-01-24 2019-01-24
US62/796,524 2019-01-24
US201962828354P 2019-04-02 2019-04-02
US62/828,354 2019-04-02
US201962832118P 2019-04-10 2019-04-10
US62/832,118 2019-04-10
PCT/US2019/062798 WO2020112542A1 (en) 2018-11-29 2019-11-22 Combination compositions comprising a beta-lactamase inhibitor and uses thereof

Publications (3)

Publication Number Publication Date
JP2022511732A JP2022511732A (ja) 2022-02-01
JP2022511732A5 true JP2022511732A5 (cg-RX-API-DMAC7.html) 2022-11-30
JP7558165B2 JP7558165B2 (ja) 2024-09-30

Family

ID=70852663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527977A Active JP7558165B2 (ja) 2018-11-29 2019-11-22 β-ラクタマーゼ阻害剤を含む組み合わせ組成物およびその使用

Country Status (17)

Country Link
US (1) US12544395B2 (cg-RX-API-DMAC7.html)
EP (1) EP3886798B1 (cg-RX-API-DMAC7.html)
JP (1) JP7558165B2 (cg-RX-API-DMAC7.html)
KR (1) KR102979279B1 (cg-RX-API-DMAC7.html)
CN (1) CN113382713A (cg-RX-API-DMAC7.html)
AU (1) AU2019386849B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021010095A2 (cg-RX-API-DMAC7.html)
CA (1) CA3121130A1 (cg-RX-API-DMAC7.html)
DK (1) DK3886798T3 (cg-RX-API-DMAC7.html)
ES (1) ES3067680T3 (cg-RX-API-DMAC7.html)
FI (1) FI3886798T3 (cg-RX-API-DMAC7.html)
IL (1) IL283330B2 (cg-RX-API-DMAC7.html)
MA (1) MA54319A (cg-RX-API-DMAC7.html)
PT (1) PT3886798T (cg-RX-API-DMAC7.html)
SG (1) SG11202105505TA (cg-RX-API-DMAC7.html)
TW (1) TWI846759B (cg-RX-API-DMAC7.html)
WO (1) WO2020112542A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105101970B (zh) 2013-01-10 2018-11-20 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
KR102396753B1 (ko) 2014-06-11 2022-05-12 베나토알엑스 파마슈티컬스, 인크. 베타-락타마제 억제제
EP3347008B1 (en) 2015-09-11 2022-03-09 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors
AU2017290060B2 (en) 2016-06-30 2021-07-22 Qpex Biopharma, Inc Boronic acid derivatives and therapeutic uses thereof
EP3494121B1 (en) 2016-08-04 2021-10-06 Venatorx Pharmaceuticals, Inc. Boron-containing compounds
PH12019502037B1 (en) 2017-03-06 2024-06-05 Everest Medicines Singapore Pte Ltd Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
EP3630782A4 (en) 2017-05-26 2021-03-03 Venatorx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
CN112424209A (zh) 2018-04-20 2021-02-26 Qpex生物制药有限公司 硼酸衍生物及其治疗用途
US12173018B2 (en) 2018-05-25 2024-12-24 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
DK3886798T3 (da) 2018-11-29 2026-04-20 Basilea Pharmaceutica Int Ag Allschwil Kombinationssammensætninger, som omfatter en beta-lactamase-hæmmer, og anvendelser deraf
EP3946364B1 (en) * 2019-04-02 2025-11-19 Venatorx Pharmaceuticals, Inc. Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof
US12636297B2 (en) 2019-06-19 2026-05-26 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
US12637481B2 (en) 2020-03-18 2026-05-26 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
IL297458A (en) 2020-05-05 2022-12-01 Qpex Biopharma Inc Boronic acid derivatives and their synthesis, polymorphic forms and medicinal uses
EP4319760A4 (en) * 2021-04-05 2025-01-08 Qpex Biopharma, Inc. CEFTIBUTENE DOSAGE REGIMEN
CN122374318A (zh) * 2023-11-21 2026-07-10 巴斯利尔药物阿尔施维尔国际股份公司 口服递送的β-内酰胺酶抑制剂的柠檬酸盐配位复合物及其用途

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1A (en) * 1836-07-13 John Ruggles Locomotive steam-engine for rail and other roads
IE41109B1 (en) 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
US7271186B1 (en) 2002-12-09 2007-09-18 Northwestern University Nanomolar β-lactamase inhibitors
JP2007505950A (ja) 2003-06-10 2007-03-15 フルクラム・ファーマシューティカルズ・インコーポレーテッド β−ラクタマーゼ阻害剤およびその使用方法
ES2899606T3 (es) 2004-03-30 2022-03-14 Millennium Pharm Inc Síntesis de compuestos de ésteres y ácidos borónicos
CN1965838A (zh) 2005-11-17 2007-05-23 李海超 含头孢匹胺和β-内酰胺酶抑制剂的药物组合物
KR101403164B1 (ko) 2005-12-07 2014-06-03 바실리어 파마슈티카 아게 베타-락타마아제 저해제 및 모노박탐 항생물질의 유용한조합
CN101129382B (zh) 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
US20100120715A1 (en) 2007-11-13 2010-05-13 Burns Christopher J Beta-lactamase inhibitors
EA201000774A1 (ru) * 2007-11-13 2010-12-30 Новартис Интернэшнл Фармасьютикл Лтд. Ингибиторы бета-лактамазы
JP5038509B2 (ja) 2008-01-18 2012-10-03 メルク・シャープ・エンド・ドーム・コーポレイション β−ラクタマーゼ阻害剤
WO2010049751A1 (en) 2008-10-29 2010-05-06 Institut National De La Recherche Agronomique Lipochitooligosaccharides stimulating arbuscular mycorrhizal symbiosis
US20100292185A1 (en) 2009-05-12 2010-11-18 Burns Christopher J Beta-lactamase inhibitors
EP2458995A1 (en) 2009-07-28 2012-06-06 Anacor Pharmaceuticals, Inc. Trisubstituted boron-containing molecules
RU2599791C2 (ru) 2010-08-10 2016-10-20 Ремпекс Фармасьютикэлз, Инч. Циклические бороновые кислотно-эфирные производные и их использование в терапии
EP2768503A1 (en) 2011-07-26 2014-08-27 Wockhardt Limited Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
WO2013053372A1 (en) 2011-10-13 2013-04-18 Therabor Pharmaceuticals Boronic acid inhibitors of beta-lactamases
WO2013056163A1 (en) 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
KR101288157B1 (ko) 2011-12-07 2013-07-19 백병하 기존 세파계 항생제 및 베타 락타마제 저해제로 배합된 내성균주에 기인한 감염증의 치료 및 예방을 위한 복합항생제
SG10201605152SA (en) 2011-12-22 2016-08-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
EP2814483A2 (en) 2012-02-15 2014-12-24 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
DE102012101680A1 (de) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
MX2015006715A (es) 2012-12-03 2015-08-14 Hoffmann La Roche Compuestos de acido triazolboronico sustituido.
JP6403219B2 (ja) 2012-12-07 2018-10-10 ベナトルクス ファーマシューティカルズ,インク. ベータ−ラクタマーゼ阻害剤
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
KR20150103270A (ko) 2013-01-04 2015-09-09 렘펙스 파머수티클스 인코퍼레이티드 보론산 유도체 및 그의 치료적 용도
AU2014204045B2 (en) 2013-01-04 2018-10-18 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN105101970B (zh) 2013-01-10 2018-11-20 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
WO2014151958A1 (en) 2013-03-14 2014-09-25 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
MA39171A1 (fr) 2014-01-10 2017-07-31 Glaxosmithkline Intellectual Property (No 2) Ltd Dérivés d'hydroxy formamide et leur utilisation
WO2015157618A1 (en) 2014-04-11 2015-10-15 The Texas A&M University System Novel inhibitors of the new delhi metallo beta lactamase (ndm-1)
WO2015171398A1 (en) 2014-05-05 2015-11-12 Rempex Pharmaceuticals, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
US10385074B2 (en) 2014-05-05 2019-08-20 Rempex Pharmaceuticals, Inc. Synthesis of boronate salts and uses thereof
AU2015264418A1 (en) * 2014-05-19 2016-11-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US9511142B2 (en) 2014-06-11 2016-12-06 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
US20150361107A1 (en) 2014-06-11 2015-12-17 VenatoRx Pharmaceuticals, Inc. Orally bioavailable beta-lactamase inhibitors
US20150361108A1 (en) 2014-06-11 2015-12-17 VenatoRx Pharmaceuticals, Inc. Orally bioavailable beta-lactamase inhibitors
KR102396753B1 (ko) 2014-06-11 2022-05-12 베나토알엑스 파마슈티컬스, 인크. 베타-락타마제 억제제
AU2015284307A1 (en) 2014-07-01 2017-02-02 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016035846A1 (ja) 2014-09-04 2016-03-10 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤
ES2761778T3 (es) 2014-12-19 2020-05-21 Rempex Pharmaceuticals Inc Aparato y proceso de flujo continuo para la producción de derivados de ácido borónico
EP3347008B1 (en) 2015-09-11 2022-03-09 Venatorx Pharmaceuticals, Inc. Beta-lactamase inhibitors
WO2017100537A1 (en) 2015-12-10 2017-06-15 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
CN105801610B (zh) 2016-04-19 2018-05-18 武汉维舜医药科技有限公司 新型广谱β-内酰胺酶抑制剂
AU2017290060B2 (en) * 2016-06-30 2021-07-22 Qpex Biopharma, Inc Boronic acid derivatives and therapeutic uses thereof
EP3494121B1 (en) 2016-08-04 2021-10-06 Venatorx Pharmaceuticals, Inc. Boron-containing compounds
PH12019502037B1 (en) 2017-03-06 2024-06-05 Everest Medicines Singapore Pte Ltd Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
CN106946924A (zh) 2017-05-11 2017-07-14 蚌埠中实化学技术有限公司 一种3‑羧基苯硼酸的制备方法
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2020056048A1 (en) 2018-09-12 2020-03-19 VenatoRx Pharmaceuticals, Inc. Combination compositions comprising a beta-lactamase inhibitor
DK3886798T3 (da) 2018-11-29 2026-04-20 Basilea Pharmaceutica Int Ag Allschwil Kombinationssammensætninger, som omfatter en beta-lactamase-hæmmer, og anvendelser deraf
EP3946364B1 (en) 2019-04-02 2025-11-19 Venatorx Pharmaceuticals, Inc. Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof
EP4225321A4 (en) 2020-10-07 2024-11-20 Venatorx Pharmaceuticals, Inc. PROCESS FOR BORON-CONTAINING COMPOUNDS

Similar Documents

Publication Publication Date Title
ES2555279T3 (es) Neuroprotección en enfermedades desmielinizantes
JP5044404B2 (ja) ロフルミラストを含有する水性医薬調剤
JP6273589B2 (ja) 安定化されたカリスバメートの小児用懸濁液
JP5714512B2 (ja) 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物
JP2010520166A5 (cg-RX-API-DMAC7.html)
JP2011079859A5 (cg-RX-API-DMAC7.html)
FI3886798T3 (fi) Beetalaktamaasi-inhibiittoria käsittäviä yhdistelmäkoostumuksia ja niiden käyttöjä
JP2021525787A5 (cg-RX-API-DMAC7.html)
ES2449340T3 (es) Compuestos calcimiméticos para su uso en el tratamiento de trastornos intestinales
US20140256661A1 (en) Pharmaceutical compositions for rectal administration
BRPI0616415A2 (pt) métodos para tratamento e prevenção de otite média, utilizando surfactantes não-iÈnicos para facilitar a liberação transmembrana do fármaco no ouvido médio
JP2006523723A (ja) 医薬的に活性な化合物を調節して導入する方法
US20200376094A1 (en) Wide-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same
US20080045572A1 (en) Pharmaceutical Composition Comprising Roflumilast or the N-Oxide of Roflumilast
JP6073202B2 (ja) 静脈におけるウイルスの治療
ES2459444T3 (es) Combinación sinérgica de compuestos analgésicos
KR20120083344A (ko) 세프타롤린을 사용한 박테리아 감염 치료용 조성물 및 방법
CN115607545A (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
JP7149991B2 (ja) 発泡剤を含む抗微生物組成物
JP2020172441A (ja) シデロフォア型抗菌用医薬組成物
CN117396202A (zh) 给药方案
JP2009538822A5 (cg-RX-API-DMAC7.html)
JP2003171266A (ja) キシリトールを含有する解熱性調剤
JP5985985B2 (ja) 胃腸への影響が減少した即効型ナプロキセン組成物
JP5364330B2 (ja) アゼラスチンとアンブロキソールとを含有する医薬組成物